The interactions between TGF-β and HPSE have been elucidated in studies showing that HPSE inhibition or strategies, such as the use of BMP-7, a TGF-β antagonist, prevent fibrotic progression and chronic pro-fibrotic damage following acute kidney injury [70,71]. This evidence concerns the gene TGFB1 and acute kidney injury.